Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 1
2003 2
2004 1
2009 2
2010 1
2013 1
2016 2
2017 3
2018 5
2019 5
2020 4
2021 5
2022 9
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Intradialytic hypotension: beyond hemodynamics.
Hajal J, Joubran N, Sleilaty G, Chacra D, Saliba Y, Assaad S, Chelala D, Fares N. Hajal J, et al. Among authors: chelala d. Physiol Res. 2019 Oct 25;68(5):793-805. doi: 10.33549/physiolres.934080. Epub 2019 Aug 19. Physiol Res. 2019. PMID: 31424249 Free article.
Immune checkpoint inhibitors renal side effects and management.
Rassy EE, Kourie HR, Rizkallah J, Karak FE, Hanna C, Chelala DN, Ghosn M. Rassy EE, et al. Among authors: chelala dn. Immunotherapy. 2016 Dec;8(12):1417-1425. doi: 10.2217/imt-2016-0099. Immunotherapy. 2016. PMID: 28000536 Review.
Routine laboratory testing in hemodialysis: how frequently is it needed?
Chidiac C, Chelala D, Nassar D, Beaini C, Azar H, Finianos S, Boueri C, Hawi J, Abdo I, Aoun M. Chidiac C, et al. Among authors: chelala d. BMC Nephrol. 2022 Oct 27;23(1):344. doi: 10.1186/s12882-022-02971-9. BMC Nephrol. 2022. PMID: 36303122 Free PMC article.
The nephrotoxicity of immune checkpoint inhibitor-based combinations.
El Rassy E, Bakouny Z, Yared F, Chelala DN, El Karak F, Ghosn M. El Rassy E, et al. Among authors: chelala dn. Eur J Cancer. 2018 Nov;103:274-278. doi: 10.1016/j.ejca.2018.07.126. Epub 2018 Sep 6. Eur J Cancer. 2018. PMID: 30196990 No abstract available.
VEGF-C attenuates renal damage in salt-sensitive hypertension.
Beaini S, Saliba Y, Hajal J, Smayra V, Bakhos JJ, Joubran N, Chelala D, Fares N. Beaini S, et al. Among authors: chelala d. J Cell Physiol. 2019 Jun;234(6):9616-9630. doi: 10.1002/jcp.27648. Epub 2018 Oct 30. J Cell Physiol. 2019. PMID: 30378108
39 results